Maplight Therapeutics, Inc. · NASDAQ:MPLT
Kreitzer Anatol sold 36,284 Maplight Therapeutics, Inc. shares (Form 4)
Traded Jul 15 to Jul 17, 2026 · Filed Jul 20, 2026
From Jul 15 to Jul 17, 2026, Kreitzer Anatol (Chief Discovery Officer) sold 36,284 Maplight Therapeutics, Inc. shares at an average US$37.09 for US$1.35M under a trading plan, leaving 174,906 shares. Filed Jul 20, 2026 (Form 4).
- Sold
- 36,284 shares
- Price
- US$37.09 average (US$36.13 to US$38.39)
- Value
- US$1.35M
- Holding after
- 174,906 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Discovery Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 15, 2026 | Voting Common Stock | Sale | 5,545 | US$36.13 | 205,645 | Direct |
| Jul 15, 2026 | Voting Common Stock | Sale | 4,510 | US$36.94 | 201,135 | Direct |
| Jul 16, 2026 | Voting Common Stock | Sale | 7,464 | US$36.66 | 193,671 | Direct |
| Jul 16, 2026 | Voting Common Stock | Sale | 1,592 | US$37.44 | 192,079 | Direct |
| Jul 17, 2026 | Voting Common Stock | Sale | 2,833 | US$37.05 | 189,246 | Direct |
| Jul 17, 2026 | Voting Common Stock | Sale | 14,140 | US$37.70 | 175,106 | Direct |
| Jul 17, 2026 | Voting Common Stock | Sale | 200 | US$38.39 | 174,906 | Direct |
Source
Related
- Maplight Therapeutics, Inc.
- Kreitzer Anatol
- Maplight Therapeutics, Inc. shareholders
- Form 4 · Kreitzer Anatol · Oct 16, 2026
- Form 4 · Kreitzer Anatol · Aug 19, 2026
- Form 4 · Kreitzer Anatol · Apr 29, 2026
- Form 4 · Kreitzer Anatol · Apr 17, 2026
- Form 4 · Foff Erin Pennock · Oct 16, 2026
- Form 4 · Gillis Jonathan · Oct 16, 2026
- Form 4 · Kroeger Christopher A. · Oct 16, 2026
- Form 4 · Hanson Kristopher · Oct 16, 2026
- Form 4 · Lillie James Woodruff · Oct 16, 2026